Basic Information
Res Nova Bio is dedicated to the development of cancer suppression anti-angiogenic immunotherapy. The company is currently conducting a Phase III stem cell clinical trial for COVID-19 related Acute Respiratory Distress Syndrome (ARDS).
Res Nova Bio, Inc.
United States of America
unclear
--
--
--
Enterprise Profile
Industrial Sector
Technology
Concept
Application Scenarios